A new formulation of a drug to prevent excessive bleeding in women after they give birth could save thousands of lives in poorer countries, according to a study co-led by the World Health Organization (WHO).
The drug, called carbetocin and made by Ferring Pharmaceuticals, could prove a useful alternative to oxytocin — currently recommended as the first-choice medicine for preventing excessive bleeding after childbirth.
Oxytocin needs to be transported and stored at between 2 and 8 degrees Celsius, making it tricky to use in many poor countries where infrastructure and power supply can be limited.
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.